Multiple Sclerosis (MS) progresses at an unpredictable rate, but predictions on the disease course in each patient would be extremely useful to tailor therapy to the individual needs. We explore different machine learning (ML) approaches to predict whether a patient will shift from the initial Relapsing-Remitting (RR) to the Secondary Progressive (SP) form of the disease, using only "real world" data available in clinical routine. The clinical records of 1624 outpatients (207 in the SP phase) attending the MS service of Sant'Andrea hospital, Rome, Italy, were used. Predictions at 180, 360 or 720 days from the last visit were obtained considering either the data of the last available visit (Visit-Oriented setting), comparing four classical M...
Abstract Objective No relapse risk prediction tool is currently available to guide treatment selecti...
Background: Multiple sclerosis has an extremely variable natural course. In most patients, disease s...
Background: The ability to better predict disease progression represents a major unmet need in multi...
Background and Objectives: Research in Multiple Sclerosis (MS) has recently focused on extracting kn...
Research in Multiple Sclerosis (MS) has recently focused on extracting knowledge from real-world cli...
To explore the value of machine learning methods for predicting multiple sclerosis disease course.16...
OBJECTIVE:To explore the value of machine learning methods for predicting multiple sclerosis disease...
Multiple Sclerosis is a chronic inflammatory disease, affecting the Central Nervous System and leadi...
The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine learning...
Machine learning (ML) applied to patient-reported (PROs) and clinical-assessed outcomes (CAOs) could...
Abstract The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine...
The course of multiple sclerosis begins with a relapsing-remitting phase, which evolves into a secon...
Multiple Sclerosis (MS) is a chronic disease that causes the disruption of the ability of the nervou...
Background: Achieving an accurate clinical course description in Multiple Sclerosis (MS) is a very h...
Multiple Sclerosis is a degenerative condition of the central nervous system that affects nearly 2.5...
Abstract Objective No relapse risk prediction tool is currently available to guide treatment selecti...
Background: Multiple sclerosis has an extremely variable natural course. In most patients, disease s...
Background: The ability to better predict disease progression represents a major unmet need in multi...
Background and Objectives: Research in Multiple Sclerosis (MS) has recently focused on extracting kn...
Research in Multiple Sclerosis (MS) has recently focused on extracting knowledge from real-world cli...
To explore the value of machine learning methods for predicting multiple sclerosis disease course.16...
OBJECTIVE:To explore the value of machine learning methods for predicting multiple sclerosis disease...
Multiple Sclerosis is a chronic inflammatory disease, affecting the Central Nervous System and leadi...
The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine learning...
Machine learning (ML) applied to patient-reported (PROs) and clinical-assessed outcomes (CAOs) could...
Abstract The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine...
The course of multiple sclerosis begins with a relapsing-remitting phase, which evolves into a secon...
Multiple Sclerosis (MS) is a chronic disease that causes the disruption of the ability of the nervou...
Background: Achieving an accurate clinical course description in Multiple Sclerosis (MS) is a very h...
Multiple Sclerosis is a degenerative condition of the central nervous system that affects nearly 2.5...
Abstract Objective No relapse risk prediction tool is currently available to guide treatment selecti...
Background: Multiple sclerosis has an extremely variable natural course. In most patients, disease s...
Background: The ability to better predict disease progression represents a major unmet need in multi...